Immune-Onc Therapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
January 06, 2023
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$131,000,000

Company Info
Founders
Charlene Liao
Company Description
Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
Market
Cancer Immunotherapy
Location
Palo Alto, California, USA
Coinvestors
Leukemia & Lymphoma Society Therapy Acceleration Program, Proxima VC, Triwise Capital, WuXi Biologics

Links